ATE403653T1 - Pyridin-substituierte furanderivate als raf- kinase inhibitoren - Google Patents
Pyridin-substituierte furanderivate als raf- kinase inhibitorenInfo
- Publication number
- ATE403653T1 ATE403653T1 AT02777001T AT02777001T ATE403653T1 AT E403653 T1 ATE403653 T1 AT E403653T1 AT 02777001 T AT02777001 T AT 02777001T AT 02777001 T AT02777001 T AT 02777001T AT E403653 T1 ATE403653 T1 AT E403653T1
- Authority
- AT
- Austria
- Prior art keywords
- sub
- sup
- kinase inhibitors
- raf
- pyridine
- Prior art date
Links
- 229940043355 kinase inhibitor Drugs 0.000 title abstract 2
- 239000003757 phosphotransferase inhibitor Substances 0.000 title abstract 2
- 102000009929 raf Kinases Human genes 0.000 title abstract 2
- 108010077182 raf Kinases Proteins 0.000 title abstract 2
- -1 PYRIDINE-SUBSTITUTED FURAN Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 206010007572 Cardiac hypertrophy Diseases 0.000 abstract 1
- 208000006029 Cardiomegaly Diseases 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000006726 chronic neurodegeneration Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0121485A GB0121485D0 (en) | 2001-09-05 | 2001-09-05 | Compounds |
| GB0121493A GB0121493D0 (en) | 2001-09-05 | 2001-09-05 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE403653T1 true ATE403653T1 (de) | 2008-08-15 |
Family
ID=26246514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02777001T ATE403653T1 (de) | 2001-09-05 | 2002-09-05 | Pyridin-substituierte furanderivate als raf- kinase inhibitoren |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7375105B2 (de) |
| EP (1) | EP1423383B1 (de) |
| AT (1) | ATE403653T1 (de) |
| DE (1) | DE60228098D1 (de) |
| ES (1) | ES2309207T3 (de) |
| WO (1) | WO2003022838A1 (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA02005106A (es) | 1999-11-22 | 2002-11-07 | Smithkline Beecham Plc | Compuestos novedosos. |
| US7235658B2 (en) * | 2000-03-06 | 2007-06-26 | Smithkline Beecham P.L.C. | Imidazol derivatives as Raf kinase inhibitors |
| GB0112348D0 (en) * | 2001-05-19 | 2001-07-11 | Smithkline Beecham Plc | Compounds |
| JP2005504793A (ja) * | 2001-09-05 | 2005-02-17 | スミスクライン ビーチャム パブリック リミテッド カンパニー | Ｒａｆキナーゼ阻害剤としてのヘテロサイクルカルボキサミド誘導体 |
| US7827944B2 (en) * | 2006-06-30 | 2010-11-09 | Gm Global Technology Operations, Inc. | System for controlling the response time of a hydraulic system |
| CL2008001626A1 (es) | 2007-06-05 | 2009-06-05 | Takeda Pharmaceuticals Co | Compuestos derivados de heterociclos fusionados, agente farmaceutico que los comprende y su uso en la profilaxis y tratamiento del cancer. |
| SG183036A1 (en) | 2007-07-17 | 2012-08-30 | Plexxikon Inc | Compounds and methods for kinase modulation, and indications therefor |
| WO2009025358A1 (ja) | 2007-08-23 | 2009-02-26 | Takeda Pharmaceutical Company Limited | 複素環化合物およびその用途 |
| EP2184285B1 (de) | 2007-08-29 | 2015-11-04 | Takeda Pharmaceutical Company Limited | Heterocyclische verbindung und ihre verwendung |
| WO2009094224A1 (en) | 2008-01-25 | 2009-07-30 | Millennium Pharmaceuticals, Inc. | Thiophenes and their use as phosphatidylinositol 3-kinase (pi3k) inhibitors |
| US8697874B2 (en) | 2008-12-01 | 2014-04-15 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
| JO3101B1 (ar) | 2008-12-02 | 2017-09-20 | Takeda Pharmaceuticals Co | مشتقات بنزوثيازول كعوامل مضادة للسرطان |
| US8796314B2 (en) | 2009-01-30 | 2014-08-05 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| US9139589B2 (en) | 2009-01-30 | 2015-09-22 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| US9090601B2 (en) | 2009-01-30 | 2015-07-28 | Millennium Pharmaceuticals, Inc. | Thiazole derivatives |
| TW201217365A (en) | 2010-08-11 | 2012-05-01 | Millennium Pharm Inc | Heteroaryls and uses thereof |
| WO2012021611A1 (en) | 2010-08-11 | 2012-02-16 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| EP2603216A4 (de) * | 2010-08-11 | 2013-12-18 | Millennium Pharm Inc | Heteroaryle und verwendungen davon |
| UY33671A (es) | 2010-10-13 | 2012-04-30 | Millenium Pharmaceuticals Inc | Heteroarilos y sus usos |
| CN111285841A (zh) | 2013-03-29 | 2020-06-16 | 雅沃科学有限责任公司 | 用于治疗癌症、神经障碍和纤维化病症的脂类呋喃、吡咯和噻吩化合物 |
| US20170312246A1 (en) | 2016-04-27 | 2017-11-02 | Avoscience, Llc | Lipidic furan, pyrrole, and thiophene compounds for use in the treatment of atrophic vaginitis |
| GB201706806D0 (en) | 2017-04-28 | 2017-06-14 | Sentinel Oncology Ltd | Pharmaceutical compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4735958A (en) | 1986-12-22 | 1988-04-05 | Warner-Lambert Company | Trans-6-[2-[2-(substituted-phenyl)-3- (or 4-) heteroaryl-5-substituted-1H-pyrrol-1-yl]-ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one inhibitors of cholesterol biosynthesis |
| US5792778A (en) * | 1995-08-10 | 1998-08-11 | Merck & Co., Inc. | 2-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| US5776954A (en) | 1996-10-30 | 1998-07-07 | Merck & Co., Inc. | Substituted pyridyl pyrroles, compositions containing such compounds and methods of use |
| TR200002617T2 (tr) * | 1997-12-22 | 2000-11-21 | Bayer Corporation | Aril ve heteroaril sübstitüentli heterosiklik üreler kullanılarak RAF kinazın inhibe edilmesi |
| AU1596101A (en) | 1999-11-12 | 2001-06-06 | Merck & Co., Inc. | Aliphatic amine substituted piperidyl diaryl pyrrole derivatives as antiprotozoal agents |
| WO2001034149A1 (en) * | 1999-11-12 | 2001-05-17 | Merck & Co., Inc. | Diaryl piperidyl pyrrole derivatives as antiprotozoal agents |
| MXPA02005106A (es) | 1999-11-22 | 2002-11-07 | Smithkline Beecham Plc | Compuestos novedosos. |
| JP2002037784A (ja) * | 2000-05-17 | 2002-02-06 | Nikken Chem Co Ltd | 新規チオフェンアミド化合物 |
-
2002
- 2002-09-05 DE DE60228098T patent/DE60228098D1/de not_active Expired - Fee Related
- 2002-09-05 US US10/488,650 patent/US7375105B2/en not_active Expired - Fee Related
- 2002-09-05 ES ES02777001T patent/ES2309207T3/es not_active Expired - Lifetime
- 2002-09-05 AT AT02777001T patent/ATE403653T1/de not_active IP Right Cessation
- 2002-09-05 EP EP02777001A patent/EP1423383B1/de not_active Expired - Lifetime
- 2002-09-05 WO PCT/EP2002/009944 patent/WO2003022838A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US20040248896A1 (en) | 2004-12-09 |
| ES2309207T3 (es) | 2008-12-16 |
| EP1423383B1 (de) | 2008-08-06 |
| EP1423383A1 (de) | 2004-06-02 |
| US7375105B2 (en) | 2008-05-20 |
| DE60228098D1 (de) | 2008-09-18 |
| WO2003022838A8 (en) | 2004-03-25 |
| WO2003022838A1 (en) | 2003-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE403653T1 (de) | Pyridin-substituierte furanderivate als raf- kinase inhibitoren | |
| ATE454152T1 (de) | 2-aminopyrimidin-derivate als raf-kinase-hemmer | |
| EP1631548A4 (de) | Hemmer der akt aktivität | |
| DE60112312D1 (de) | Imidazolderivate als raf-kinase-inhibitoren | |
| DE60220290D1 (de) | Pyridinderivate als inhibitoren der raf-kinase | |
| ATE512957T1 (de) | Hemmer der akt aktivität | |
| EP1737843A4 (de) | Hemmer der akt aktivität | |
| ATE381557T1 (de) | Rho-kinase inhibitoren | |
| MY142915A (en) | Rho-kinase inhibitors | |
| TW200611907A (en) | Fused heterocyclic compound | |
| NZ533310A (en) | Benzimidazoles useful as protein kinase inhibitors | |
| AU2001235844A1 (en) | Imidazol-2-carboxamide derivatives as raf kinase inhibitors | |
| DE602006007012D1 (de) | Pyridinderivate als dipeptedyl-peptidase-hemmer | |
| DE60103136D1 (de) | Imidazol derivate als raf kinase inhibitoren | |
| BRPI0407841A (pt) | inibidores heterocìclicos de quinase | |
| EA200400475A1 (ru) | Замещенные производные бензимидазола и их применение для лечения злокачественной опухоли | |
| ATE359283T1 (de) | Substituierte pyrazinonverbindungen zur behandlung von entzündungen | |
| MX2007008308A (es) | Derivados de n-(heteroaril)-1h-indol-2-carboxamidas y su utilizacion como ligandos del receptor vaniloide trpv1-. | |
| ATE419242T1 (de) | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren | |
| UA98928C2 (ru) | 1,4-дигидропиридинконденсированные гетероциклы, способ их получения, применения и композиция, которая содержит их | |
| ATE336489T1 (de) | Stickstoff enthaltende heterozyklen und ihre verwendung als raf inhibitoren | |
| ATE276259T1 (de) | Dihydroporphyrinderivate und ihre verwendung | |
| WO2000043375A3 (de) | Substituierte arylheterocyclen | |
| DK1904502T3 (da) | Antiarytmiske precursorforbindelser, fremgangsmåder til syntese og fremgangsmåder til anvendelse | |
| SG145574A1 (en) | Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |